Fingerprick test could speed up detection of blood clots and infections

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria D-dimer: * Subjects \>18 years of age. * Willing and able to provide written informed consent and comply with study procedures. * Presenting to healthcare provider for any reason\* \*All presentations are suitable for recruitment; however, the following conditions are of particular interest: Venous thromboembolism symptoms (DVT and Pulmonary embolism), subjects seeking medical attention with symptoms of respiratory tract infection (upper or lower), Acute myocardial infarction / unstable angina, Anti-inflammatory medication (current), Any regular medication for a chronic condition (other than simple painkiller or inhaler), Atrial fibrillation, Diabetes mellitus (all types except 'pre-diabetes'), Heart failure, Hypertension (\>150/90), Infection (significant current or within 3 months), Peripheral arterial disease, Surgery (within 6 weeks), Childbirth (within 8 weeks), Significant trauma, burns (within 4 weeks), Pregnancy (confirmed or suspected), Acute upper gastrointestinal haemorrhage other significant recent haemorrhage. D-dimer Exclusion Criteria: * The subject is currently receiving or has received within the past thirty (30) days of the study visit an experimental biologic or drug including either treatment or therapy. * Skin lesions or conditions that would preclude a fingerstick and or a venous blood draw. * End-stage renal failure on haemodialysis. * Life expectancy documented as less than 30 days. * Haemodynamically unstable (e.g. cardiogenic shock). * Current anticoagulation therapy (Fragmin, LMWH) within the last 30 days. * Patients taking anticoagulant therapy (DOACS, Warfarin, Heparins etc.) within the last 30 days. * The subject has previously participated in this research study CRP Inclusion criteria: * Subjects \>18 years of age. * Willing and able to provide written informed consent and comply with study procedures. * Subjects seeking medical attention with symptoms of infection, tissue injury, inflammatory disorders or associated disease. This includes but not limited to: respiratory tract infection (upper or lower), rheumatoid arthritis, Lupus, burns, trauma, inflammatory bowel disease. CRP Exclusion Criteria: * The subject is currently receiving or has received within the past thirty (30) days of the study visit an experimental biologic or drug including either treatment or therapy. * Skin lesions or conditions that would preclude a fingerstick and or a venous blood draw. * A subject with a critical illness, requiring critical intervention, or end of life or palliative care. * Subjects suffering with Myeloma, Monoclonal Gammopathy or extreme Lipaemia. * The subject has previously participated in this research study